Howard Gorder, PA
Medical · Rochester, MNNPI 1205012614
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Organogenesis Inc. accounts for 83.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $416 and has fallen 55.3% since, to $186 in 2025.
Across 52 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$1K
- Lifenet Health$62
- Kerecis Limited$49
- Melinta Therapeutics, LLC$35
- Solventum Corporation$30
- Hydrofera LLC$18
What the payments were for
- Food & beverage$1,195100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 43 | $1,001 |
| Lifenet Health | 4 | $62 |
| Kerecis Limited | 2 | $49 |
| Melinta Therapeutics, LLC | 1 | $35 |
| Solventum Corporation | 1 | $30 |
| Hydrofera LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$259
How this compares
$1,195 in reported general payments places this provider in the 85th percentile of 202 medical providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 17 | $268 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $235 |
| Penicillin V Potassium | 21 | $161 |
| Ciprofloxacin Hcl | 16 | $84 |
Paid to pharmacies, not to this prescriber.
Other medical in Rochester
- Frederick KupferRochester$798
- Kristina ThissenRogers$178K
- Cynthia KonrathMinnetonka$95K
- Tyler JohnsonWaconia$28K
- Eliza AbrahamWhite Bear Lake$19K
- Tobie MeyerMaple Grove$13K
- Emily BurkmanWhite Bear Lake$6K
- Sarah SeilerMaple Grove$4K
- Kerry GuntliEden Prairie$3K
- Katie PetersonMaple Grove$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.